Publications by authors named "Nicholas Pissimissis"
Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
Michael Koutsilieris Theodore Dimopoulos Constantine Milathianakis John Bogdanos Dimitrios Karamanolakis Nicholas Pissimissis
BJU Int
July 2007
Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml).
Dimitrios Karamanolakis Theocharis Lambou John Bogdanos Constantine Milathianakis Antigone Sourla Nicholas Pissimissis
Anticancer Res
September 2006
Whether serum testosterone (T) can become an adjunct test able to validate the PSA-weighted risk of prostate cancer (PR.CA) in the "grey" diagnostic area (PSA =3.0 to <10.
View Article and Find Full Text PDF